The global peptide synthesis market accounted for USD 0.714 billion in 2023 and is expected to reach at USD 2.86 billion by 2034 with a CAGR of 13.46% during the forecast period 2024-2034. The expansion of technology, heightened acceptance of peptides in pharmaceutical & consumer healthcare sectors, escalating prevalence of chronic ailments such as cancer, diabetes, & obesity, surge in demand for peptide-based medications, rising diabetic population, growing approvals for innovative products, increased funding for research and development, and surge in the introduction of new products for peptide synthesis are some of the key factors boosting the market growth.
Surge in the introduction of new products for peptide synthesis is predicted to boost the market growth during the forecast period. Peptide synthesis involves the step-by-step addition of individual amino acids to produce short polypeptide sequences. It is utilized to craft precise sequences representing epitopes of particular protein domains, which could be subject to modification by various groups such as phosphate moieties. For instance, in April 2022, CME Corporation introduced the Liberty 2.0-line microwave peptide synthesizers, offering improved peptide purity, synthesis efficiency, and automated capabilities.
By product, equipment was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to increase in research focused on developing innovative peptide synthesis equipment and rise in the introduction of new equipment. Additionally, reagents & consumables is predicted to grow at the fastest CAGR during the forecast period owing to growing adoption in peptide synthesis protocols, surge in advancements regarding peptide coupling reagents, and increasing number of partnerships among market participants. For instance, in September 2023, AmbioPharm teamed up with CombiGene to collaborate on the development of COZY01 peptide for Zynero, as part of their joint peptide-based pain project.
By technology, liquid phase peptide synthesis was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to the combination of increasing advancements and the incorporation of automation into liquid phase peptide synthesis has significantly decreased the expenses linked with peptide synthesis and rise in the introduction of new products. For instance, in June 2022, Evonik introduced a fresh peptide designed to enhance the efficiency of biopharmaceuticals produced through cell culture. Known as cQrex AC, this peptide provides a chemically defined and easily soluble form of L-cystine, ensuring cells receive an ample supply of this essential amino acid. Additionally, solid phase peptide synthesis (SPPS) is predicted to grow at the fastest CAGR during the forecast period owing to the solid phase peptide synthesis method offers various benefits including quick generation of linear peptides, straightforward purification, & cost-effectiveness, and growing investment in the advancement of technologies essential for this synthesis method by contract manufacturers.
By application, therapeutics was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to the existence of a robust pipeline, high volume of peptide candidates for treating type II diabetes, increasing utilization of synthesized peptides in cancer therapy, and escalating approvals by regulatory agencies. For instance, in May 2022, The FDA in the United States has granted approval for Mounjaro (tirzepatide) injection, aimed at enhancing blood sugar management in adults diagnosed with type 2 diabetes. This medication, known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is intended to be used alongside dietary adjustments and physical activity. Additionally, diagnosis is predicted to grow at the fastest CAGR during the forecast period owing to the rising advancements in peptide synthesis technology, where tools such as biomarkers and imaging agents play a crucial role in disease detection, monitoring, and personalized medicine strategies.
By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to the growing emphasis on research & development of peptide therapies due to their cost-effectiveness, efficiency, & reduced toxicity, rapid technological progress in peptide synthesizers, and increased focus on expansion by market participants. For instance, In September 2023, CordenPharma unveiled its newly enhanced facilities at its Colorado manufacturing site, intending to boost the production capacity of commercial peptides. Additionally, contract development & manufacturing organization/contract research organization is predicted to grow at the fastest CAGR during the forecast period owing to the increase in the development of new products and a robust pipeline for peptide therapeutics.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising demand for peptide synthesis techniques, increasing research & therapeutic applications, growing awareness of available peptide synthesis technologies, heightened focus on commercializing peptide drugs, and increased partnerships among market participants. For instance, in March 2023, Bachem has forged a lasting alliance with an undisclosed partner to supply substantial volumes of peptides, projected to amount to approximately CHF 500 million, spanning from 2027 to 2031. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing investment by market players, heightened awareness of innovative peptide treatments, increasing healthcare expenditures, surge in partnerships among multinational companies and local entities for distribution purposes, rising prevalence of chronic diseases, and increasing launch of new products. For instance, in January 2022, Novo Nordisk India introduced the world's inaugural 'Peptide In A Pill' for diabetes control. The peptide, known as Semaglutide, is a GLP-1 receptor analog (GLP-1 RA), belonging to a class of drugs used to manage type 2 diabetes.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Surge in the introduction of new products for peptide synthesis is predicted to boost the market growth during the forecast period. Peptide synthesis involves the step-by-step addition of individual amino acids to produce short polypeptide sequences. It is utilized to craft precise sequences representing epitopes of particular protein domains, which could be subject to modification by various groups such as phosphate moieties. For instance, in April 2022, CME Corporation introduced the Liberty 2.0-line microwave peptide synthesizers, offering improved peptide purity, synthesis efficiency, and automated capabilities.
By product, equipment was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to increase in research focused on developing innovative peptide synthesis equipment and rise in the introduction of new equipment. Additionally, reagents & consumables is predicted to grow at the fastest CAGR during the forecast period owing to growing adoption in peptide synthesis protocols, surge in advancements regarding peptide coupling reagents, and increasing number of partnerships among market participants. For instance, in September 2023, AmbioPharm teamed up with CombiGene to collaborate on the development of COZY01 peptide for Zynero, as part of their joint peptide-based pain project.
By technology, liquid phase peptide synthesis was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to the combination of increasing advancements and the incorporation of automation into liquid phase peptide synthesis has significantly decreased the expenses linked with peptide synthesis and rise in the introduction of new products. For instance, in June 2022, Evonik introduced a fresh peptide designed to enhance the efficiency of biopharmaceuticals produced through cell culture. Known as cQrex AC, this peptide provides a chemically defined and easily soluble form of L-cystine, ensuring cells receive an ample supply of this essential amino acid. Additionally, solid phase peptide synthesis (SPPS) is predicted to grow at the fastest CAGR during the forecast period owing to the solid phase peptide synthesis method offers various benefits including quick generation of linear peptides, straightforward purification, & cost-effectiveness, and growing investment in the advancement of technologies essential for this synthesis method by contract manufacturers.
By application, therapeutics was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to the existence of a robust pipeline, high volume of peptide candidates for treating type II diabetes, increasing utilization of synthesized peptides in cancer therapy, and escalating approvals by regulatory agencies. For instance, in May 2022, The FDA in the United States has granted approval for Mounjaro (tirzepatide) injection, aimed at enhancing blood sugar management in adults diagnosed with type 2 diabetes. This medication, known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is intended to be used alongside dietary adjustments and physical activity. Additionally, diagnosis is predicted to grow at the fastest CAGR during the forecast period owing to the rising advancements in peptide synthesis technology, where tools such as biomarkers and imaging agents play a crucial role in disease detection, monitoring, and personalized medicine strategies.
By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global peptide synthesis market in 2023 owing to the growing emphasis on research & development of peptide therapies due to their cost-effectiveness, efficiency, & reduced toxicity, rapid technological progress in peptide synthesizers, and increased focus on expansion by market participants. For instance, In September 2023, CordenPharma unveiled its newly enhanced facilities at its Colorado manufacturing site, intending to boost the production capacity of commercial peptides. Additionally, contract development & manufacturing organization/contract research organization is predicted to grow at the fastest CAGR during the forecast period owing to the increase in the development of new products and a robust pipeline for peptide therapeutics.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising demand for peptide synthesis techniques, increasing research & therapeutic applications, growing awareness of available peptide synthesis technologies, heightened focus on commercializing peptide drugs, and increased partnerships among market participants. For instance, in March 2023, Bachem has forged a lasting alliance with an undisclosed partner to supply substantial volumes of peptides, projected to amount to approximately CHF 500 million, spanning from 2027 to 2031. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing investment by market players, heightened awareness of innovative peptide treatments, increasing healthcare expenditures, surge in partnerships among multinational companies and local entities for distribution purposes, rising prevalence of chronic diseases, and increasing launch of new products. For instance, in January 2022, Novo Nordisk India introduced the world's inaugural 'Peptide In A Pill' for diabetes control. The peptide, known as Semaglutide, is a GLP-1 receptor analog (GLP-1 RA), belonging to a class of drugs used to manage type 2 diabetes.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Technology, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Peptide Synthesis Market Report 2023 - 2034
Peptide Synthesis Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Equipment
- Chromatography Equipment
- Peptide Synthesizers
- Lyophilizers
- Others
- Reagents & Consumables
- Other
Peptide Synthesis Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Hybrid Technology
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
Peptide Synthesis Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Research
- Diagnosis
- Therapeutics
- CNS
- Pain
- Cancer
- Respiratory
- Renal
- Metabolic
- Dermatology
- Infectious Diseases
- Cardiovascular Disorder
- GIT (Gastrointestinal Disorders)
- Others
Peptide Synthesis Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Contract Development & Manufacturing Organization/Contract Research Organization
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Peptide Synthesis Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Peptide Synthesis Market: Product Estimates & Trend Analysis
8. Peptide Synthesis Market: Technology Estimates & Trend Analysis
9. Peptide Synthesis Market: Application Estimates & Trend Analysis
10. Peptide Synthesis Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Peptide Synthesis Market
13. Europe Global Peptide Synthesis Market
14. Asia Pacific Global Peptide Synthesis Market
15. Latin America Global Peptide Synthesis Market
16. MEA Global Peptide Synthesis Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- CEM Corporation
- Anaspec
- CSBio Company Inc.
- Bachem Holding AG
- Merck KGaA
- Biotage
- AAPPTec
- Thermo Fisher Scientific
- Gyros Protein Technologies AB
- Biosynth Carbosynth (Vivitide)
